By analyzing Pharming Group's earnings estimates, investors can diagnose different trends across Pharming Group's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Pharming Group NV is based on EPS before non-recurring items and includes expenses related to employee stock options.
Housing Crash
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
Pharming Group is projected to generate 0.01 in earnings per share on the 31st of December 2025. Pharming Group earnings estimates show analyst consensus about projected Pharming Group NV EPS (Earning Per Share). It derives the highest and the lowest estimates based on Pharming Group's historical volatility. Many public companies, such as Pharming Group, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pharming Group's earnings estimates, investors can diagnose different trends across Pharming Group's analyst sentiment over time as well as compare current estimates against different timeframes. At present, Pharming Group's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.76, whereas Pretax Profit Margin is forecasted to decline to (0.03).
Pharming
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Pharming Group Earnings per Share Projection vs Actual
About Pharming Group Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pharming Group earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pharming Group estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pharming Group fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
It's important to distinguish between Pharming Group's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharming Group should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pharming Group's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.